Latest filing published 30 Jun 2026 for Hansoh Pharmaceutical Group Co. Ltd., €1.4M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Sun Yuan in Hansoh Pharmaceutical Group Co. Ltd., where the filings describe the role as chief executive. Between 14 June 2019 and 27 June 2026, the trades on record add up to 13 filings.
On the open market, the record shows 3 purchases and 3 sales worth €4.1M. The totals do not cover 3 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: no purchases and 2 sales on the market.
The latest filing, published on 30 June 2026, reports an open-market sale of €1.4M in Hansoh Pharmaceutical Group Co. Ltd. The latest purchase dates back some time: it was published 844 days ago, on 2 July 2024. Typically, a trade is published a median of 6 days after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.